Replies to post #251035 on Anavex Life Sciences Corp (AVXL)

[rayovacAAA]

THE CEO OF AVXL COMPLETELY DISAGREES!!!!!!!!!!!!!!!!!



https://seekingalpha.com/article/4344435-anavex-life-sciences-avxl-ceo-christopher-missling-on-q2-2020-results-earnings-call?part=single

Christopher Missling

So the answer to the last question is we would obviously hold a meeting depending on outcome. And regarding the first question, I would rather like to have the data speak for itself, since we don't have any preconceived outcome expectation, since this is the very first study in Parkinson's disease dementia with our drugs. So it's hard for us to formulate any scenario.

GOOD LUCK AND GOD BLESS!!!!!!!!!!!!!!

[georgejjl]

From Dr. Christopher Missling MS, PhD, MBA

...I would not interpret non-buying is a signal one way or the other. And as you said, it's also not possible to speak about it. And I can’t even say that we can to speculate this that there are moments where you cannot buy anymore because you know certain things. So I would not bring this to the forefront. I would just leave it like that we are very excited about all our programs.

PDD, Alzheimer's disease and Rett syndrome trials are currently in OPEN LABEL Extension trials. The results are obviously GREAT.

Good luck and GOD bless,

[bennyboy1]

George: to have 100% of the participants ask to continue in the OLE Trial is OUTSTANDING!! Who would want to continue with SUCCESS? Everyone that has experienced it!!!!!!! GREAT NEWS COMING!!!!!!!

[F1ash]

Anavex knows the results of the PDD trial are GREAT

Quote:

100% of eligible participants have opted into the open-label extension study as of December 16, 2019

Wouldn’t it be better if only 66% of the patients had opted for the extension?